Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BOS NASDAQ:NEO TSE:VNP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOSDB Base Metals Short ETN$6.70-8.7%$0.00$15.12▼$22.02$181KN/A150 shs24,314 shsNEONeoGenomics$11.44+4.5%$8.85$4.72▼$13.74$1.43B1.821.25 million shs1.98 million shsVNP5N PlusC$38.59-9.7%C$37.43C$8.53▼C$49.97C$3.47B0.916618516,991 shs732,732 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOSDB Base Metals Short ETN-64.98%-64.98%-64.98%-64.98%-64.98%NEONeoGenomics+0.46%+4.89%+22.21%+27.92%+47.57%VNP5N Plus+4.58%+4.20%+13.62%+46.45%+377.32%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOSDB Base Metals Short ETN$6.70-8.7%$0.00$15.12▼$22.02$181KN/A150 shs24,314 shsNEONeoGenomics$11.44+4.5%$8.85$4.72▼$13.74$1.43B1.821.25 million shs1.98 million shsVNP5N PlusC$38.59-9.7%C$37.43C$8.53▼C$49.97C$3.47B0.916618516,991 shs732,732 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOSDB Base Metals Short ETN-64.98%-64.98%-64.98%-64.98%-64.98%NEONeoGenomics+0.46%+4.89%+22.21%+27.92%+47.57%VNP5N Plus+4.58%+4.20%+13.62%+46.45%+377.32%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBOSDB Base Metals Short ETN 0.00N/AN/AN/ANEONeoGenomics 2.42Hold$13.8621.13% UpsideVNP5N Plus 3.29BuyC$43.5812.94% UpsideCurrent Analyst Ratings BreakdownLatest VNP, NEO, and BOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/8/2026NEONeoGenomics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/2/2026VNP5N Plus DesjardinsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuyC$43.00 ➝ C$50.005/25/2026VNP5N Plus ATB Cormark Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetTop PickC$45.00 ➝ C$56.505/21/2026NEONeoGenomics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/8/2026VNP5N Plus DesjardinsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuyC$35.50 ➝ C$43.005/8/2026VNP5N Plus ATB Cormark Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetTop PickC$37.50 ➝ C$45.005/8/2026VNP5N Plus National Bank FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperformC$38.00 ➝ C$41.005/8/2026VNP5N Plus Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperformC$38.00 ➝ C$45.004/29/2026NEONeoGenomics BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$11.004/29/2026NEONeoGenomics TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.00 ➝ $14.004/29/2026NEONeoGenomics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$12.00 ➝ $25.00(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBOSDB Base Metals Short ETNN/AN/AN/AN/AN/AN/ANEONeoGenomics$727.33M2.05$0.35 per share32.68$6.47 per share1.77VNP5N PlusC$420.07M8.26C$6.25 per share6.18C$2.43 per share15.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBOSDB Base Metals Short ETNN/AN/AN/AN/AN/AN/AN/AN/AN/ANEONeoGenomics-$108.03M-$0.77N/A381.33N/A-13.30%-2.80%-1.72%8/4/2026 (Estimated)VNP5N PlusC$11.26MC$0.6559.37N/A6,283.3313.95%30.00%3.16%N/ALatest VNP, NEO, and BOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026VNP5N PlusN/AC$0.28N/AC$0.28N/AC$163.91 million4/28/2026Q1 2026NEONeoGenomics$0.0058$0.01+$0.0042-$0.13$184.54 million$186.67 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBOSDB Base Metals Short ETNN/A0.00%N/AN/AN/ANEONeoGenomicsN/AN/AN/AN/AN/AVNP5N PlusN/A2.25%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBOSDB Base Metals Short ETNN/AN/AN/ANEONeoGenomics0.414.424.06VNP5N Plus68.962.691.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBOSDB Base Metals Short ETNN/ANEONeoGenomics98.50%VNP5N Plus24.94%Insider OwnershipCompanyInsider OwnershipBOSDB Base Metals Short ETNN/ANEONeoGenomics1.10%VNP5N Plus4.91%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBOSDB Base Metals Short ETNN/A27,000N/ANot OptionableNEONeoGenomics2,500130.21 million128.78 millionOptionableVNP5N Plus78089.94 millionN/ANot OptionableVNP, NEO, and BOS HeadlinesRecent News About These Companies5N Plus Inc. (TSE:VNP) Receives Average Rating of "Buy" from BrokeragesJune 7 at 4:22 AM | americanbankingnews.comThis Stellar Canadian Stock Is up 498% This Past Year, and There’s More Growth AheadMay 31, 2026 | ca.finance.yahoo.com5N Plus (TSE:VNP) Shares Down 6.2% - Should You Sell?May 31, 2026 | americanbankingnews.comAn impressive growth stock worth buying even if you only have $200 to investMay 15, 2026 | msn.comA Look At 5N Plus (TSX:VNP) Valuation After Its Strong Recent Share Price MomentumMay 10, 2026 | finance.yahoo.com5N Plus Inc. Reports First Quarter 2026 Financial ResultsMay 6, 2026 | finance.yahoo.comThe Canadian Stocks I’d Prioritize if I Had $5,000 to Invest Right NowMay 3, 2026 | fool.ca5N Plus Inc. to Release First Quarter 2026 Results on May 6, 2026 and Hold Its Virtual Annual General Meeting on May 7, 2026April 29, 2026 | finance.yahoo.comThis Canadian junior is a crucial critical minerals stock, analyst saysApril 23, 2026 | cantechletter.comCAssessing 5N Plus (TSX:VNP) Valuation After CFO Transition And Leadership Succession ShakeupApril 14, 2026 | finance.yahoo.com5N Plus Inc. Announces Appointment of Alban Fournier as Chief Financial OfficerApril 13, 2026 | ca.finance.yahoo.comThis Stellar Canadian Stock Is Up 497% This Past Year and There’s More Growth AheadApril 1, 2026 | ca.finance.yahoo.com5N Plus Inc. Announces Upcoming Changes to Board of DirectorsMarch 16, 2026 | finance.yahoo.com2 Growth Stocks Ready to Skyrocket in 2026 and AfterMarch 11, 2026 | fool.caPublic market insider selling at 5N Plus (VNP)March 4, 2026 | theglobeandmail.comHow The Investment Story For 5N Plus (TSX:VNP) Is Shifting With New Valuation AssumptionsFebruary 25, 2026 | finance.yahoo.com5N Plus Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial ResultsFebruary 24, 2026 | newswire.ca5N Plus Inc. to Release Fourth Quarter 2025 Results on February 24, 2026February 17, 2026 | tmcnet.comThese 2 Canadian Stocks Have the Booster Power to Rocket Higher in 2026February 13, 2026 | ca.finance.yahoo.comDesjardins Sticks to Its Buy Rating for 5N Plus (VNP)February 7, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20263 AI Data Center Stocks Worth Watching for Capital RotationBy Ryan Hasson | May 15, 2026Nebius Group Pulls Back 9% After a Downgrade Despite Strong EarningsBy Ryan Hasson | May 19, 2026Why These Three Big Buybacks Are Sending Very Different Signals to InvestorsBy Leo Miller | June 1, 2026A Deep Dive Into NVIDIA’s Latest Portfolio MovesBy Leo Miller | May 19, 2026VNP, NEO, and BOS Company DescriptionsDB Base Metals Short ETN NYSEARCA:BOS$6.70 -0.64 (-8.72%) As of 06/5/2026NeoGenomics NASDAQ:NEO$11.44 +0.49 (+4.47%) Closing price 04:00 PM EasternExtended Trading$11.45 +0.01 (+0.09%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.5N Plus TSE:VNPC$38.59 -4.13 (-9.67%) As of 04:00 PM Eastern5N+ is a leading global producer of specialty semiconductors and performance materials. The Company's ultra pure materials often form the core element of its customers' products. These customers rely on 5N+'s products to enable performance and sustainability in their own products. 5N+ deploys a range of proprietary and proven technologies to develop and manufacture its products. The Company's products enable various applications in several key industries, including renewable energy, security, space, pharmaceutical, medical imaging and industrial. Headquartered in Montreal, Quebec, 5N+ operates R&D, manufacturing and commercial centers in strategically located facilities around the world including Europe, North America and Asia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Corning Is Paving AI's Future With Glass The J.M. Smucker Company’s Dividend: Too Sweet to Ignore? Why's Amazon Suddenly Lagging the S&P 500, and Is It a Warning? Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking? From Crypto to AI: Insiders Are Trading These 3 Stocks The Case for Intel Over Pure-Play Quantum Firms Has Temu-Owner PDD's Story Changed After Double Miss? Campbell's Soup Stock: Deep Value and a 7% Dividend Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
